Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Clin Infect Dis ; 45(12): 1550-8, 2007 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-18190315

RESUMEN

BACKGROUND: Community-acquired methicillin-resistant Staphylococcus aureus strains have recently been associated with severe necrotizing infections. Greater than 75% of these strains carry the genes for Panton-Valentine leukocidin (PVL), suggesting that this toxin may mediate these severe infections. However, to date, studies have not provided evidence of toxin production. METHODS: Twenty-nine community-acquired methicillin-resistant Staphylococcus aureus and 2 community-acquired methicillin-susceptible S. aureus strains were collected from patients with infections of varying severity. Strains were analyzed for the presence of lukF-PV and SCCmecA type. PVL production in lukF-PV gene-positive strains was measured by ELISA, and the amount produced was analyzed relative to severity of infection. RESULTS: Only 2 of the 31 strains tested, 1 methicillin-resistant Staphylococcus aureus abscess isolate and 1 nasal carriage methicillin-susceptible S. aureus isolate, were lukF-PV negative. All methicillin-resistant Staphylococcus aureus strains were SCCmec type IV. PVL was produced by all strains harboring lukF-PV, although a marked strain-to-strain variation was observed. Twenty-six (90%) of 29 strains produced 50-350 ng/mL of PVL; the remaining strains produced PVL in excess of 500 ng/mL. The quantity of PVL produced in vitro did not correlate with severity of infection. CONCLUSIONS: Although PVL likely plays an important role in the pathogenesis of these infections, its mere presence is not solely responsible for the increased severity. Factors that up-regulate toxin synthesis in vivo could contribute to more-severe disease and worse outcomes in patients with community-acquired methicillin-resistant Staphylococcus aureus infection.


Asunto(s)
Toxinas Bacterianas/metabolismo , Exotoxinas/metabolismo , Leucocidinas/metabolismo , Resistencia a la Meticilina , Infecciones Estafilocócicas/microbiología , Staphylococcus aureus/metabolismo , Factores de Virulencia/metabolismo , Exotoxinas/fisiología , Humanos , Leucocidinas/fisiología , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/patogenicidad
2.
J Infect Dis ; 195(2): 202-11, 2007 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-17191165

RESUMEN

Extracellular protein toxins contribute to the pathogenesis of a wide variety of Staphylococcus aureus infections. The present study investigated the effects that cell-wall active antibiotics and protein-synthesis inhibitors have on transcription and translation of genes for Panton-Valentine leukocidin, alpha-hemolysin, and toxic-shock syndrome toxin 1, in both methicillin-sensitive and methicillin-resistant S. aureus. Subinhibitory concentrations of nafcillin induced and prolonged mRNA for Panton-Valentine leukocidin, alpha-toxin, and toxic-shock syndrome toxin 1 and increased toxin production. In contrast, clindamycin and linezolid markedly suppressed translation, but not transcription, of toxin genes. These results suggest (1) that protein-synthesis inhibition is an important consideration in the selection of antimicrobial agents to treat serious infections caused by toxin-producing gram-positive pathogens and (2) that, by inducing and enhancing toxin production, inadvertent use of beta-lactam antibiotics to treat methicillin-resistant S. aureus infections may contribute to worse outcomes.


Asunto(s)
Antibacterianos/farmacología , Exotoxinas/biosíntesis , Resistencia a la Meticilina , Inhibidores de la Síntesis de la Proteína/farmacología , Staphylococcus aureus/patogenicidad , Acetamidas/farmacología , Animales , Toxinas Bacterianas/biosíntesis , Toxinas Bacterianas/genética , Clindamicina/farmacología , Enterotoxinas/biosíntesis , Enterotoxinas/genética , Exotoxinas/genética , Proteínas Hemolisinas/biosíntesis , Proteínas Hemolisinas/efectos de los fármacos , Proteínas Hemolisinas/genética , Leucocidinas/biosíntesis , Leucocidinas/genética , Linezolid , Meticilina/farmacología , Pruebas de Sensibilidad Microbiana , Nafcilina/farmacología , Oxazolidinonas/farmacología , Conejos , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/crecimiento & desarrollo , Superantígenos/biosíntesis , Superantígenos/efectos de los fármacos , Superantígenos/genética , Vancomicina/farmacología , Virulencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA